You are not currently logged in.
Access your personal account or get JSTOR access through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Insulin Receptors in Human Circulating Cells and Fibroblasts
James R. Gavin, Jesse Roth, Phyllis Jen and Pierre Freychet
Proceedings of the National Academy of Sciences of the United States of America
Vol. 69, No. 3 (Mar., 1972), pp. 747-751
Published by: National Academy of Sciences
Stable URL: http://www.jstor.org/stable/61372
Page Count: 5
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Human lymphocytes obtained from fasted adult subjects and cultured human tumor lymphocytes were investigated for specific insulin receptors. By use of monoiodoinsulin, specific insulin binding sites were demonstrated in peripheral human lymphocytes, cultured human lymphocytes, and in other types of human circulating cells. Insulins and insulin derivatives that varied in their potency to stimulate glucose oxidation in the fat cell and to inhibit binding of [125I]insulin to purified plasma membranes, varied in an analogous fashion in their ability to inhibit the binding of labeled insulin to human lymphocytes. Hormones that had no effect on the binding of insulin to fat cells or liver membranes also had no effect on the binding of insulin to lymphocytes. Binding was time and temperature dependent; dissociation of [125I]insulin was rapid upon addition of 10 μ M insulin. These findings afford a direct approach to the study of endocrine disorders in man.
Proceedings of the National Academy of Sciences of the United States of America © 1972 National Academy of Sciences